Early oral contraceptive use and breast cancer: theoretical effects of latency.
AUTOR(ES)
McPherson, K
RESUMO
Many cancers and other chronic diseases are associated with a long delay between exposure to a putative risk factor and subsequent diagnosis. This presents well recognised problems in the elucidation of suspected risk factors by epidemiological methods. In this paper we discuss the interpretation in epidemiological studies of the effect of a possible risk factor when population exposure is recent and rapidly changing. An important contemporary example concerns the study of early oral contraceptive (OC) use in relation to the subsequent risk of breast cancer. Computer simulations reported here indicate that plausible delays in the manifestation of any effect on breast cancer incidence make it difficult to exclude early OC use as a risk factor for breast cancer, even when large well conducted epidemiological studies show no apparent increased risk. Methods for detecting a 'latent' effect are discussed.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1052548Documentos Relacionados
- Oral contraceptive use before first birth and risk of breast cancer: a case control study
- Oral contraceptive use and breast and ovarian cancer mortality in Switzerland.
- Medical and psychosocial effects of early discharge after surgery for breast cancer: randomised trial
- THE BREAST RECONSTRUCTION PROCESS OF WOMEN WITH BREAST CANCER: A THEORETICAL MODEL
- Chemotherapy for early-stage breast cancer: a brief history